Navigation Links
Apieron, Inc. Files Infringement Complaint Against Aerocrine AB, Aerocrine AG and Mr. Magnus Pelles
Date:7/16/2009

MENLO PARK, Calif., July 16 /PRNewswire/ -- Today, Apieron, Inc. reported that it filed a patent infringement complaint against Aerocine AB, Solna, Sweden, Aerocrine AG, Bad Homburg, Germany and Mr. Mangus Pelles, Usingen, Germany in the Regional Court of Mannheim, Germany. Apieron, makers of the Insight(TM) eNO System for measurement of exhaled nitric oxide, presented this complaint against Aerocrine on the grounds that they are offering and putting on the market portable and stationary analyzers to detect the nitric oxide content in breath, which Apieron considers to be infringing the German part of its European Patent EP 0 892 926.

About Apieron, Inc.

Apieron, Inc. is a private venture-backed medical device company dedicated to developing innovative solutions to improve the standard of care for people with asthma. Its Insight(TM) eNO System measures exhaled nitric oxide (eNO) which is a well established indicator of airway inflammation for asthma management. Utilizing a proprietary biosensor, Apieron's Insight eNO System can detect trace amounts of nitric oxide in a patient's breath. It is highly accurate, non-invasive, safe, easy to use, and provides results in less than a minute.

    Contact:
    Steve DiMattia
    (646) 201-5445


'/>"/>
SOURCE Apieron, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1

Related medicine news :

1. Burg Simpson Files Yasmin/Yaz Lawsuits
2. New York Law Firm Files Lawsuit Against Manufacturer of Zicam Nasal Spray and Drugstore Chain That Sold Product
3. CareFusion Files Amended Form 10 Registration Statement With SEC
4. Novo Nordisk Insulin Analogs Have Proven Safety Profiles
5. Discus Dental Files Suit to Protect BriteSmile(R) Trademark
6. WuXi PharmaTech Files 2008 Annual Report on Form 20-F
7. Simcere Pharmaceutical Group Files Annual Report on Form 20-F
8. Wyeth Files Definitive Proxy Statement and Announces Date for Annual Meeting of Stockholders
9. Watson Files FDA Application for Generic Mucinex(R) D
10. Profiles International Releases New Report on Top 5 Management Failures and Remedies for Success
11. Johnson & Johnson Files Arbitration Demand Against Schering-Plough to Resolve Dispute Over Agreements for REMICADE(R) and SIMPONI(TM)
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/29/2017)... , ... March 29, 2017 , ... Immunotherapy has emerged ... number of cancers and is touted to be the next revolution in our fight ... has been in the form of immune checkpoint inhibitors such as PD-1 and PD-L1 ...
(Date:3/29/2017)... PA (PRWEB) , ... March 29, 2017 , ... The ... W’80, WG’81, and Julie Taffet Moelis, W’81, have made a $10 million gift to ... deferred admission opportunity that will provide a pathway to a Wharton MBA for highly-qualified ...
(Date:3/28/2017)... ... ... Tuesday, March 28, 2017, is the annual American Diabetes Association Alert Day, ... find out if they are at risk for developing Type 2 diabetes. In recognition ... by programming the LAX pylons the color red. Downtown’s U.S. Bank Tower Crown Lights ...
(Date:3/28/2017)... ... March 28, 2017 , ... Resoundant, Inc., the developer of ... Siemens Healthineers annual customer education symposium, a world-class learning conference that offers educational ... 27 - 31, 2017 at the Atlanta Marriott Marquis in Atlanta, Georgia. , ...
(Date:3/28/2017)... Seattle, WA (PRWEB) , ... March 28, 2017 ... ... reach a 22% share of all holidays (IBT World Travel Trends Report). As ... physically challenging, include a range in temperatures, and prolonged sun exposure. In response, ...
Breaking Medicine News(10 mins):
(Date:3/29/2017)... Research and Markets has announced the addition of the ... their offering. ... The ablation device global market is expected to grow at high ... Ablation is the minimally invasive therapeutic tissue excision procedure used ... removal, to the removal of abnormally conducting cardiac tissue in atrial ...
(Date:3/29/2017)... SAN FRANCISCO , March 29, 2017 /PRNewswire/ ... an option agreement with Bionure Farma, S.L. for ... BN201 and to BN119 in the field of ... million plus sales-based royalties. The agreement provides ... stage assets with a differentiated product profile. Under ...
(Date:3/29/2017)... 29, 2017   Royal Philips (NYSE: ... technology, and PathAI, a company that develops artificial ... aim to develop solutions that improve the precision ... other diseases. The partnership aims to build deep ... of artificial intelligence to be applied to massive ...
Breaking Medicine Technology: